SCYNEXIS, INC. | |||||||
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS | |||||||
(in thousands, except share and per share data) | |||||||
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
Revenue | $ | 64 | $ | 64 | |||
Operating expenses: | |||||||
Research and development | 9,684 | 5,326 | |||||
Selling, general and administrative | 2,241 | 1,971 | |||||
Total operating expenses | 11,925 | 7,297 | |||||
Loss from operations | (11,861) | (7,233) | |||||
Other expense (income): | |||||||
Loss on extinguishment of debt | 814 | ? | |||||
Amortization of debt issuance costs and discount | 200 | 111 | |||||
Interest income | (281) | (167) | |||||
Interest expense | 367 | 379 | |||||
Warrant liabilities fair value adjustment | 6,522 | (3,554) | |||||
Derivative liability fair value adjustment | 3,425 | ? | |||||
Total other expense (income): | 11,047 | (3,231) | |||||
Net loss | $ | (22,908) | $ | (4,002) | |||
Net loss per share – basic and diluted | $ | (0.46) | $ | (0.12) | |||
Weighted average common shares outstanding – basic and diluted | 49,317,575 | 33,579,025 | |||||
SCYNEXIS, INC. | |||||||
UNAUDITED CONDENSED BALANCE SHEETS | |||||||
(in thousands, except share and per share data) | |||||||
March 31, 2019 | December 31, 2018 | ||||||
Cash and cash equivalents | $ | 12,950 | $ | 11,439 | |||
Short-term investments | 26,110 | 32,718 | |||||
Total current assets | 40,073 | 51,463 | |||||
Operating lease right-of-use asset | 3,317 | ? | |||||
Total assets | 45,067 | 53,170 | |||||
Total current liabilities | 4,638 | 5,877 | |||||
Warrant liabilities | 7,508 | 986 | |||||
Loan payable expected to be refinanced | ? | 15,082 | |||||
Convertible debt and derivative liability | 18,296 | ? | |||||
Operating lease liability | 3,295 | ? | |||||
Total liabilities | 33,737 | 21,945 | |||||
Total stockholders' equity | 11,330 | 31,225 | |||||
Total liabilities and stockholders' equity | $ | 45,067 | $ | 53,170 |